# | Title | Journal | Year | Citations |
---|
1 | Drug delivery systems: Advanced technologies potentially applicable in personalized treatments | EPMA Journal | 2010 | 293 |
2 | Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016 | EPMA Journal | 2016 | 292 |
3 | Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine | EPMA Journal | 2013 | 262 |
4 | Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine | EPMA Journal | 2016 | 241 |
5 | The primary vascular dysregulation syndrome: implications for eye diseases | EPMA Journal | 2013 | 226 |
6 | General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine | EPMA Journal | 2012 | 218 |
7 | Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control | EPMA Journal | 2010 | 193 |
8 | The crucial role of multiomic approach in cancer research and clinically relevant outcomes | EPMA Journal | 2018 | 184 |
9 | Taiwan’s healthcare report 2010 | EPMA Journal | 2010 | 175 |
10 | Flammer syndrome | EPMA Journal | 2014 | 159 |
11 | Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine | EPMA Journal | 2017 | 158 |
12 | Particle radiotherapy with carbon ion beams | EPMA Journal | 2013 | 126 |
13 | Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles | EPMA Journal | 2019 | 125 |
14 | Predictive, Preventive and Personalised Medicine as the hardcore of ‘Horizon 2020’: EPMA position paper | EPMA Journal | 2014 | 123 |
15 | Pattern recognition for predictive, preventive, and personalized medicine in cancer | EPMA Journal | 2017 | 119 |
16 | Biobanks in the era of personalized medicine: objectives, challenges, and innovation | EPMA Journal | 2015 | 116 |
17 | Mental stress as consequence and cause of vision loss: the dawn of psychosomatic ophthalmology for preventive and personalized medicine | EPMA Journal | 2018 | 111 |
18 | Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon? | EPMA Journal | 2017 | 109 |
19 | Identification of clinical trait–related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer | EPMA Journal | 2019 | 109 |
20 | Physical activity recommendations for public health: development and policy context | EPMA Journal | 2011 | 103 |
21 | Bridging Ayurveda with evidence-based scientific approaches in medicine | EPMA Journal | 2014 | 98 |
22 | Artificial intelligence supported patient self-care in chronic heart failure: a paradigm shift from reactive to predictive, preventive and personalised care | EPMA Journal | 2019 | 96 |
23 | Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases | EPMA Journal | 2017 | 94 |
24 | Traditional Chinese medicine and new concepts of predictive, preventive and personalized medicine in diagnosis and treatment of suboptimal health | EPMA Journal | 2014 | 90 |
25 | Flavonoids against the Warburg phenotype—concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism | EPMA Journal | 2020 | 88 |
26 | EPMA position paper in cancer: current overview and future perspectives | EPMA Journal | 2015 | 86 |
27 | Prevention of fatigue and insomnia in shift workers—a review of non-pharmacological measures | EPMA Journal | 2016 | 85 |
28 | All around suboptimal health — a joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine | EPMA Journal | 2021 | 85 |
29 | “Pre-metastatic niches” in breast cancer: are they created by or prior to the tumour onset? “Flammer Syndrome” relevance to address the question | EPMA Journal | 2017 | 82 |
30 | Early decrease in blood platelet count is associated with poor prognosis in COVID-19 patients—indications for predictive, preventive, and personalized medical approach | EPMA Journal | 2020 | 82 |
31 | Development and testing of gold nanoparticles for drug delivery and treatment of heart failure: a theranostic potential for PPP cardiology | EPMA Journal | 2013 | 81 |
32 | Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry | EPMA Journal | 2017 | 81 |
33 | Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases? | EPMA Journal | 2013 | 80 |
34 | Retinal venous pressure: the role of endothelin | EPMA Journal | 2015 | 79 |
35 | Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy | EPMA Journal | 2018 | 75 |
36 | Feeling cold and other underestimated symptoms in breast cancer: anecdotes or individual profiles for advanced patient stratification? | EPMA Journal | 2017 | 73 |
37 | Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles | EPMA Journal | 2021 | 71 |
38 | Caution, “normal” BMI: health risks associated with potentially masked individual underweight—EPMA Position Paper 2021 | EPMA Journal | 2021 | 70 |
39 | Probiotics and immunity: provisional role for personalized diets and disease prevention | EPMA Journal | 2015 | 69 |
40 | Endothelial dysfunction in cardiovascular disease and Flammer syndrome—similarities and differences | EPMA Journal | 2017 | 68 |
41 | Specific properties of probiotic strains: relevance and benefits for the host | EPMA Journal | 2018 | 68 |
42 | Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine | EPMA Journal | 2021 | 68 |
43 | Comparative study of probiotic effects of Lactobacillus and Bifidobacteria strains on cholesterol levels, liver morphology and the gut microbiota in obese mice | EPMA Journal | 2017 | 67 |
44 | The discovery of the Flammer syndrome: a historical and personal perspective | EPMA Journal | 2017 | 66 |
45 | Retinal vein occlusions: The potential impact of a dysregulation of the retinal veins | EPMA Journal | 2010 | 65 |
46 | Behavior, nutrition and lifestyle in a comprehensive health and disease paradigm: skills and knowledge for a predictive, preventive and personalized medicine | EPMA Journal | 2012 | 64 |
47 | Exercise in multiple sclerosis -- an integral component of disease management | EPMA Journal | 2012 | 63 |
48 | Preventive, predictive, and personalized medicine for effective and affordable cancer care | EPMA Journal | 2018 | 63 |
49 | COVID-19 what have we learned? The rise of social machines and connected devices in pandemic management following the concepts of predictive, preventive and personalized medicine | EPMA Journal | 2020 | 63 |
50 | Overview of healthcare in the UK | EPMA Journal | 2010 | 61 |